+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Yuhan Corp (000100) - Financial and Strategic SWOT Analysis Review

  • PDF Icon

    SWOT Analysis

  • 44 Pages
  • June 2023
  • GlobalData
  • ID: 4319033
Yuhan Corp (000100) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by the publisher to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.


Yuhan Corp (Yuhan) discovers, develops, manufactures and markets pharmaceutical products. The company offers APIs and intermediates for antibiotic, antiviral, antifungal, anti-thrombotic, anti-inflammatory, anti-diabetic and anti-hyperlipidemics. The company offers finished goods for the treatment of hypertension, coronary artery disease, hyperlipidemia, cerebral thrombosis and other diseases. Yuhan provides custom synthesis services for other pharmaceutical and biopharmaceutical companies. It offers active pharmaceutical ingredients (API) and finished products in domestic as well as international market. Yuhan operates R&D and manufacturing facilities in Seoul. The company offers its products and services through its sales and distribution branches. Yuhan is headquartered in Seoul, South Korea.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company

Table of Contents

Section 1 - About the Company
  • Yuhan Corp - Key Facts
  • Yuhan Corp - Key Employees
  • Yuhan Corp - Key Employee Biographies
  • Yuhan Corp - Major Products and Services
  • Yuhan Corp - History
  • Yuhan Corp - Company Statement
  • Yuhan Corp - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
  • Affiliate
  • Joint Venture
Section 2 - Company Analysis
  • Company Overview
  • Yuhan Corp - Business Description
  • Business Segment: Household & Healthcare
  • Performance
  • Performance
  • Business Segment: License
  • Performance
  • Business Segment: Others
  • Performance
  • Business Segment: Overseas
  • Overview
  • Performance
  • Business Segment: Pharmaceuticals
  • Overview
  • Performance
  • R&D Overview
  • Yuhan Corp - Corporate Strategy
  • Yuhan Corp - SWOT Analysis
  • SWOT Analysis - Overview
  • Yuhan Corp - Strengths
  • Yuhan Corp - Weaknesses
  • Yuhan Corp - Opportunities
  • Yuhan Corp - Threats
  • Yuhan Corp - Key Competitors
Section 3 - Company Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Performance Chart
  • Financial Performance
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Company’s Lifesciences Financial Deals and Alliances
  • Yuhan Corp, Pharmaceuticals & Healthcare, Deals By Year, 2017 to YTD 2023
  • Yuhan Corp, Pharmaceuticals & Healthcare, Deals By Type, 2017 to YTD 2023
  • Yuhan Corp, Recent Deals Summary
Section 5 - Appendix
  • Methodology
  • Ratio Definitions
  • About the Publisher
  • Contact the Publisher
  • Disclaimer
List of Tables
  • Yuhan Corp, Key Facts
  • Yuhan Corp, Key Employees
  • Yuhan Corp, Key Employee Biographies
  • Yuhan Corp, Major Products and Services
  • Yuhan Corp, History
  • Yuhan Corp, Other Locations
  • Yuhan Corp, Subsidiaries
  • Yuhan Corp, Affiliate
  • Yuhan Corp, Joint Venture
  • Yuhan Corp, Key Competitors
  • Yuhan Corp, Ratios based on current share price
  • Yuhan Corp, Annual Ratios
  • Yuhan Corp, Interim Ratios
  • Yuhan Corp, Pharmaceuticals & Healthcare, Deals By Year, 2017 to YTD 2023
  • Yuhan Corp, Pharmaceuticals & Healthcare, Deals By Type, 2017 to YTD 2023
  • Yuhan Corp, Recent Deals Summary
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • Yuhan Corp, Performance Chart (2018 - 2022)
  • Yuhan Corp, Ratio Charts
  • Yuhan Corp, Pharmaceuticals & Healthcare, Deals By Year, 2017 to YTD 2023
  • Yuhan Corp, Pharmaceuticals & Healthcare, Deals by Type, 2017 to YTD 2023

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Huons Global Co Ltd
  • Yooyoung Pharm Co Ltd
  • Green Cross Holdings Corp
  • Dongsung Pharm Co Ltd
  • CrystalGenomics Inc
  • Yuyu Pharma Inc
  • AptaBio Therapeutics Inc
  • Daewoong Pharmaceutical Co Ltd
  • Daewoong Pharmaceutical Co Ltd
  • AptaBio Therapeutics Inc
  • Yuyu Pharma Inc
  • GC Corp
  • CrystalGenomics Inc
  • Dongsung Pharm Co Ltd
  • Yooyoung Pharm Co Ltd
  • Huons Global Co Ltd